Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03940534
Other study ID # 6195-001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 9, 2018
Est. completion date February 26, 2019

Study information

Verified date May 2019
Source Intent Solutions, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A novel device, TAD, has been developed to aid adherence to prescribed regimens and may have a roll in hospice pain management. This study aims to assess medication adherence relating to missed doses or improperly timed doses with and without the aid of a mobile device as a primary endpoint. Secondary endpoints will be patient, nursing, and provider satisfaction.


Description:

This study is a randomized crossover study in which patients will be randomized to start with or without a mobile device assisting the patient or caregiver in using the device. The investigators aim to enroll 20 patients across 3 sites. Each patient is expected to participate in the study for 12 weeks. After the first 2 weeks of participation, the patient will either begin using the mobile device to assist or will stop using the mobile device for the next 2 weeks. after the initial 4 weeks, the patient will choose to continue with or without using the mobile device.


Recruitment information / eligibility

Status Completed
Enrollment 8
Est. completion date February 26, 2019
Est. primary completion date February 26, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- any patient taking morphine ER or Oxycontin on one of three hospice home teams

Exclusion Criteria:

- pregnancy

- inability to demonstrate competent use of the device

- age less than 18

Study Design


Related Conditions & MeSH terms


Intervention

Device:
TAD
TAD is a device used to aid medication adherence.

Locations

Country Name City State
United States Haven: Advanced Illness Care Gainesville Florida
United States Haven: Advanced Illness Care Lake City Florida
United States Haven: Advanced Illness Care Palatka Florida

Sponsors (1)

Lead Sponsor Collaborator
Intent Solutions, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Difference from Scheduled Dosing Time The time difference between when the patient took the dose and the scheduled time of administration. through study completion, up to 1 year
Primary Missed Doses The number of missed doses that occurred during the study. through study completion, up to 1 year
Secondary Patient Satisfaction: scale of 1 to 5 The patient's satisfaction will be measured on a scale of 1 to 5 (from 1 being extremely dissatisfied to 5 being extremely satisfied). Satisfaction will be assessed with the follow questions:
Using the mail order pharmacy to receive your pain medication?
Ease of using the TAD device to dispense your pain medication?
Ease of using the mobile device application with the TAD device? (ONLY when using the mobile application)
The ability of the device to provide you the dose of pain medication at the correct time?
The overall experience of using the TAD device?
through study completion, up to 1 year
Secondary Nurse Satisfaction: scale of 1 to 5 The nurse's satisfaction will be measured on a scale of 1 to 5 (from 1 being extremely dissatisfied to 5 being extremely satisfied). Satisfaction will be assessed with the follow questions:
Using the mail order pharmacy get your patient their pain medication?
Your patient's ability to use the TAD device to dispense their pain medication?
Your patient's ability to use the mobile device application with the TAD device? (ONLY when using the mobile application)
The ability of the device to increase compliance of the pain medication?
The overall experience of using the TAD device?
through study completion, up to 1 year
Secondary Physician Satisfaction: scale of 1 to 5 The physician's satisfaction will be measured on a scale of 1 to 5 (from 1 being extremely dissatisfied to 5 being extremely satisfied). Satisfaction will be assessed with the follow questions:
Using the mail order pharmacy get your patient their pain medication?
Your patient's ability to use the TAD device to dispense their pain medication?
Your patient's ability to use the mobile device application with the TAD device? (ONLY when using the mobile application)
The ability of the device to increase compliance of the pain medication?
The overall experience of using the TAD device?satisfaction will be measured on a scale of 1 to 5 for satisfaction of using the mail order pharmacy, ease of using the device, ease of using the mobile device, the ability of the device to accurately provide the dose, and overall experience with the device.
through study completion, up to 1 year
See also
  Status Clinical Trial Phase
Completed NCT04709640 - Pilot Study to Improve Medication Management in Older Adults N/A
Completed NCT03257579 - Myocardial Infarction Prescription Duration Adherence Study N/A
Completed NCT05376397 - Testing THRIVE 365 for Black Sexual Minority Men (On The Daily) N/A
Withdrawn NCT03427008 - A Pilot Study of mDOT for Immunosuppressant Adherence in Adult Kidney Transplant Recipients N/A
Completed NCT03805451 - Life Steps for PrEP for Youth N/A
Withdrawn NCT03292393 - Social Norms and Antihypertensive Medication Adherence N/A
Completed NCT02914730 - Insulin Dosing Practices in Persons With Diabetes on Multiple Daily Injections
Not yet recruiting NCT02876848 - A Novel E-Health Approach in Optimizing Treatment for Seniors (OPTIMUM Study) N/A
Completed NCT02823795 - The Supporting Patient Activation in Transition to Home Intervention N/A
Completed NCT02797262 - Measuring and Monitoring Adherence to ART With Pill Ingestible Sensor System N/A
Completed NCT02066935 - Non-adherence to Immunosuppressives in Kidney Transplantation in Brazil Multicenter Study
Completed NCT01934608 - The Effect of Synching Prescription Refills on Adherence N/A
Completed NCT01770314 - Study to Test the Efficacy of Online Education to Increase Safe Use of Opioid Medication. Phase 2
Completed NCT01741311 - Secondary HIV Prevention and Adherence Among HIV-infected Drug Users N/A
Recruiting NCT01105104 - An Enhanced Medication Monitoring Program Phase 1
Withdrawn NCT01430702 - Feasibility of Using a Telemedicine Medication Delivery Unit for Older Adults N/A
Completed NCT01859273 - Adherence Enhancement for Renal Transplant Patients N/A
Completed NCT01118208 - Blister Packaging Medication to Increase Treatment Adherence and Clinical Response N/A
Completed NCT00848224 - Improving Adherence to Pharmacological Treatment N/A
Completed NCT06034301 - Pill Bottle vs Reminder App N/A